[?1034hARFI:HISTOLOGY ANALYSIS
======================
Valid Patients (29): [56, 58, 59, 60, 62, 63, 64, 70, 71, 72, 73, 76, 78, 79, 82, 83, 84, 86, 87, 89, 91, 92, 93, 94, 95, 96, 99, 102, 104]

INDEX LESIONS
=============
ARFI Sensitivity (Exact) = 7/29 (0.24)
ARFI Sensitivity (NN) = 21/29 (0.72)
Exact ARFI:Histology Matches:
	62 (IOS: 3, Gleason: 7)
	71 (IOS: 3, Gleason: 7)
	73 (IOS: 2, Gleason: 7)
	76 (IOS: 2, Gleason: 7)
	82 (IOS: 1, Gleason: 6)
	83 (IOS: 3, Gleason: 7)
	89 (IOS: 2, Gleason: 7)
NN ARFI:Histology Matches: [58, 59, 60, 62, 71, 72, 73, 76, 78, 82, 83, 84, 86, 87, 89, 91, 93, 94, 96, 99, 104]
Missed Cases: [56, 63, 64, 70, 79, 92, 95, 102]

ARFI LESIONS
============
22/29 (0.76) were clinically significant lesions
	28/29 (0.97) read lesions were posterior
	1/29 (0.03) read lesions were anterior
False ARFI reads:
	Non-clinically-significant PCA: []
	Atrophy: []
	BPH: []

CLINICALLY-SIGNIFICANT HISTOLOGY LESIONS
========================================
23/35 (0.66) of clinically-significant lesions were detected
	30/35 (0.86) of these lesions were posterior
	5/35 (0.14) of these lesions were anterior

ARFI LESION BENIGN CONFOUNDERS
==============================
Atrophy: [59, 60, 72, 87, 93, 96]
BPH: [58, 79, 91, 96]
